Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Cell Biosci 15 , 137 (2025)
1 Introduction Cardiovascular disease (CVD) continues to be a significant global health concern, with ischemic stroke and acute myocardial infarction ranking as the second and third leading causes of death worldwide in 2019 ( The complex interaction between diabetes mellitus (DM) and cardiovascular events complicates patient management
Today, medications make that outcome more accessible
You want around-the-clock support
See the patient information sheet below
Stroke prevention with the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) inhibitor evolocumab added to statin in high-risk patients with stable atherosclerosis
US$ 23.72
US$ 20.10
US$ 20.90
US$ 26.67
US$ 21.20
